3-149212456-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000096.4(CP):āc.389A>Gā(p.His130Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H130Q) has been classified as Likely benign.
Frequency
Consequence
NM_000096.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CP | NM_000096.4 | c.389A>G | p.His130Arg | missense_variant | 2/19 | ENST00000264613.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CP | ENST00000264613.11 | c.389A>G | p.His130Arg | missense_variant | 2/19 | 1 | NM_000096.4 | P1 | |
CP | ENST00000490639.5 | n.421A>G | non_coding_transcript_exon_variant | 2/17 | 1 | ||||
CP | ENST00000455472.3 | c.509A>G | p.His170Arg | missense_variant | 3/4 | 5 | |||
CP | ENST00000481169.5 | c.389A>G | p.His130Arg | missense_variant, NMD_transcript_variant | 2/18 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461642Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727136
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Deficiency of ferroxidase Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jun 29, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CP-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces histidine with arginine at codon 130 of the CP protein (p.His130Arg). The histidine residue is moderately conserved and there is a small physicochemical difference between histidine and arginine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at